GenomOncology
Cleveland, US · Ohio LLC · 1 known investors
GenomOncology builds precision oncology software, including its Precision Oncology Platform (POP) and a Pathology Workbench, along with content and curation data products for clinical genomics. It serves clinicians and researchers in cancer care through healthcare IT and bioinformatics tools.
Founders & leadership
LP
Len PagonDirector
JS
Jeff SmithExecutive Officer
JS
Jonathan SeatonDirector
BL
Brian LadenDirector
LZ
Lee ZapisDirector
BW
Brad WertzExecutive Officer, Director
JY
Justin YeakleyChief Information Security Officer & SVP, Product Development
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$3.2MraisedApr 2020 · 10 investors · Other Health CareRule 506(b)
▶$3.2MraisedApr 2020 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan SeatonDirector
- Brian LadenDirector
- Len PagonDirector
- Jeff SmithExecutive Officer
- Brad WertzExecutive Officer, Director
- Lee ZapisDirector
- Offering amount
- $4.2M
- Amount sold
- $3.2M
- First sale
- Apr 2020
- Incorporated
- Limited Liability Company, Ohio
- Federal exemptions
- 06b
▶$1.4MraisedNov 2019 · 13 investors · Other Health CareRule 506(b)
▶$1.4MraisedNov 2019 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Len PagonDirector
- Jeff SmithExecutive Officer
- Jonathan SeatonDirector
- Brian LadenDirector
- Lee ZapisDirector
- Brad WertzExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $1.4M
- First sale
- Nov 2019
- Incorporated
- Limited Liability Company, Ohio
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- GenomOncology Receives Investment from TriStar Technology Ventures - FinSMEsfinsmes.com · 2014
- JumpStart Invests $250,000 in GenomOncology - BioSpacebiospace.com · 2012